These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 22884511
1. Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer. Zhang P, Wang J, Wang D, Wang H, Shan F, Chen L, Hou Y, Wang E, Lu CL. Int Immunopharmacol; 2012 Nov; 14(3):252-60. PubMed ID: 22884511 [Abstract] [Full Text] [Related]
2. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H. Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [Abstract] [Full Text] [Related]
8. Antitumor immunity by a dendritic cell vaccine encoding secondary lymphoid chemokine and tumor lysate on murine prostate cancer. Lu J, Zhang Q, Liang CM, Xia SJ, Zhong CP, Wang DW. Asian J Androl; 2008 Nov; 10(6):883-9. PubMed ID: 18958352 [Abstract] [Full Text] [Related]
13. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR. J Immunother; 2007 Dec 15; 30(8):789-97. PubMed ID: 18049330 [Abstract] [Full Text] [Related]
14. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. Wang J, Saffold S, Cao X, Krauss J, Chen W. J Immunol; 1998 Nov 15; 161(10):5516-24. PubMed ID: 9820528 [Abstract] [Full Text] [Related]